MedTrace Logo

Comparison Between NEOSORB Plus and NEOSORB

NCT02431039 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-08-14

No results posted yet for this study

Summary

This study is to investigate whether NEOSORB Plus antibacterial suture (chlorhexidine diacetate coated PGLA910) is not inferior to NEOSORB suture (PGLA910) in the points of intraoperative handling.

Conditions

  • Skin Reaction to Suture Material

Interventions

DEVICE

NEOSORB PLUS

Fascia and subcutaneous tissue repaired by antibacterial suture materials (Chlorhexidine diacetate coated PGLA910)

DEVICE

NEOSORB

Fascia and subcutaneous tissue repaired by non-antibacterial suture materials (PGLA910)

Sponsors & Collaborators

  • Medical Research Collaborating Center, Seoul, Korea

    collaborator OTHER

  • Korea Health Industry Development Institute

    collaborator OTHER_GOV

  • Samyang Biopharmaceuticals Corporation

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chang Wook Jeong, M.D.,Ph.D. · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02431039 on ClinicalTrials.gov